Comparative effectiveness of in-person vs. remote delivery of the Common Elements Treatment Approach for addressing mental and behavioral health problems among adolescents and young adults in Zambia: protocol of a three-arm randomized controlled trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
19 May 2022
Historique:
received: 17 02 2022
accepted: 19 04 2022
entrez: 19 5 2022
pubmed: 20 5 2022
medline: 24 5 2022
Statut: epublish

Résumé

In low- and middle-income countries (LMIC), there is a substantial gap in the treatment of mental and behavioral health problems, which is particularly detrimental to adolescents and young adults (AYA). The Common Elements Treatment Approach (CETA) is an evidence-based, flexible, transdiagnostic intervention delivered by lay counselors to address comorbid mental and behavioral health conditions, though its effectiveness has not yet been tested among AYA. This paper describes the protocol for a randomized controlled trial that will test the effectiveness of traditional in-person delivered CETA and a telehealth-adapted version of CETA (T-CETA) in reducing mental and behavioral health problems among AYA in Zambia. Non-inferiority of T-CETA will also be assessed. This study is a hybrid type 1 three-arm randomized trial to be conducted in Lusaka, Zambia. Following an apprenticeship model, experienced non-professional counselors in Zambia will be trained as CETA trainers using a remote, technology-delivered training method. The new CETA trainers will subsequently facilitate technology-delivered trainings for a new cohort of counselors recruited from community-based partner organizations throughout Lusaka. AYA with mental and behavioral health problems seeking services at these same organizations will then be identified and randomized to (1) in-person CETA delivery, (2) telehealth-delivered CETA (T-CETA), or (3) treatment as usual (TAU). In the superiority design, CETA and T-CETA will be compared to TAU, and using a non-inferiority design, T-CETA will be compared to CETA, which is already evidence-based in other populations. At baseline, post-treatment (approximately 3-4 months post-baseline), and 6 months post-treatment (approximately 9 months post-baseline), we will assess the primary outcomes such as client trauma symptoms, internalizing symptoms, and externalizing behaviors and secondary outcomes such as client substance use, aggression, violence, and health utility. CETA trainer and counselor competency and cost-effectiveness will also be measured as secondary outcomes. Mixed methods interviews will be conducted with trainers, counselors, and AYA participants to explore the feasibility, acceptability, and sustainability of technology-delivered training and T-CETA provision in the Zambian context. Adolescents and young adults in LMIC are a priority population for the treatment of mental and behavioral health problems. Technology-delivered approaches to training and intervention delivery can expand the reach of evidence-based interventions. If found effective, CETA and T-CETA would help address a major barrier to the scale-up and sustainability of mental and behavioral treatments among AYA in LMIC. ClinicalTrials.gov NCT03458039 . Prospectively registered on May 10, 2021.

Sections du résumé

BACKGROUND BACKGROUND
In low- and middle-income countries (LMIC), there is a substantial gap in the treatment of mental and behavioral health problems, which is particularly detrimental to adolescents and young adults (AYA). The Common Elements Treatment Approach (CETA) is an evidence-based, flexible, transdiagnostic intervention delivered by lay counselors to address comorbid mental and behavioral health conditions, though its effectiveness has not yet been tested among AYA. This paper describes the protocol for a randomized controlled trial that will test the effectiveness of traditional in-person delivered CETA and a telehealth-adapted version of CETA (T-CETA) in reducing mental and behavioral health problems among AYA in Zambia. Non-inferiority of T-CETA will also be assessed.
METHODS METHODS
This study is a hybrid type 1 three-arm randomized trial to be conducted in Lusaka, Zambia. Following an apprenticeship model, experienced non-professional counselors in Zambia will be trained as CETA trainers using a remote, technology-delivered training method. The new CETA trainers will subsequently facilitate technology-delivered trainings for a new cohort of counselors recruited from community-based partner organizations throughout Lusaka. AYA with mental and behavioral health problems seeking services at these same organizations will then be identified and randomized to (1) in-person CETA delivery, (2) telehealth-delivered CETA (T-CETA), or (3) treatment as usual (TAU). In the superiority design, CETA and T-CETA will be compared to TAU, and using a non-inferiority design, T-CETA will be compared to CETA, which is already evidence-based in other populations. At baseline, post-treatment (approximately 3-4 months post-baseline), and 6 months post-treatment (approximately 9 months post-baseline), we will assess the primary outcomes such as client trauma symptoms, internalizing symptoms, and externalizing behaviors and secondary outcomes such as client substance use, aggression, violence, and health utility. CETA trainer and counselor competency and cost-effectiveness will also be measured as secondary outcomes. Mixed methods interviews will be conducted with trainers, counselors, and AYA participants to explore the feasibility, acceptability, and sustainability of technology-delivered training and T-CETA provision in the Zambian context.
DISCUSSION CONCLUSIONS
Adolescents and young adults in LMIC are a priority population for the treatment of mental and behavioral health problems. Technology-delivered approaches to training and intervention delivery can expand the reach of evidence-based interventions. If found effective, CETA and T-CETA would help address a major barrier to the scale-up and sustainability of mental and behavioral treatments among AYA in LMIC.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT03458039 . Prospectively registered on May 10, 2021.

Identifiants

pubmed: 35590348
doi: 10.1186/s13063-022-06319-4
pii: 10.1186/s13063-022-06319-4
pmc: PMC9117594
doi:

Banques de données

ClinicalTrials.gov
['NCT03458039']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

417

Subventions

Organisme : NIMH NIH HHS
ID : T32 MH103210
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH109436
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH115495
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

J Emerg Nurs. 2013 Nov;39(6):539-46
pubmed: 21937097
Am J Community Psychol. 2012 Dec;50(3-4):415-27
pubmed: 22711269
J Assoc Nurses AIDS Care. 2008 Nov-Dec;19(6):443-9
pubmed: 19007722
N Engl J Med. 2013 Jun 6;368(23):2182-91
pubmed: 23738545
Br J Psychiatry. 2005 Dec;187:559-67
pubmed: 16319409
AIDS. 2004 Jun;18 Suppl 2:S55-65
pubmed: 15319744
Curr Opin Psychiatry. 2010 Jul;23(4):356-62
pubmed: 20520546
Ann Behav Med. 2008 Dec;36(3):270-9
pubmed: 18836789
J Adolesc Health. 2006 Jun;38(6):643-8
pubmed: 16730590
Behav Res Ther. 2011 Sep;49(9):523-8
pubmed: 21788012
Am J Pharm Educ. 2007 Dec 15;71(6):110
pubmed: 19503694
Ment Health Serv Res. 2005 Mar;7(1):5-20
pubmed: 15832690
Assessment. 2020 Sep;27(6):1335-1348
pubmed: 29871499
J Clin Child Adolesc Psychol. 2014;43(6):902-14
pubmed: 24400677
Qual Life Res. 2010 Aug;19(6):887-97
pubmed: 20401552
J Sch Health. 2010 Sep;80(9):453-60
pubmed: 20690977
Bull World Health Organ. 2004 Nov;82(11):858-66
pubmed: 15640922
Lancet. 2011 Nov 5;378(9803):1664-75
pubmed: 22008426
J Child Adolesc Ment Health. 2007 Jun;19(1):1-17
pubmed: 25865319
Br J Psychiatry. 2011 Dec;199(6):441-2
pubmed: 22130744
Int J Telemed Appl. 2018 Nov 01;2018:9602821
pubmed: 30519259
J Clin Child Psychol. 2001 Sep;30(3):376-84
pubmed: 11501254
Indian J Psychiatry. 2020 Sep;62(Suppl 3):S377-S379
pubmed: 33227074
J Am Acad Child Adolesc Psychiatry. 2010 Nov;49(11):1145-54
pubmed: 20970702
Front Psychiatry. 2019 Nov 13;10:806
pubmed: 31798470
Cogn Behav Pract. 2014 May;21(2):111-123
pubmed: 25620867
Lancet. 2011 Oct 22;378(9801):1515-25
pubmed: 22008427
J Telemed Telecare. 2001;7 Suppl 2:35-40
pubmed: 11747654
Lancet. 2009 Jun 6;373(9679):1966-72
pubmed: 19428100
Indian J Psychol Med. 2020 Oct 7;42(5 Suppl):69S-74S
pubmed: 33354068
J Child Psychol Psychiatry. 2008 Mar;49(3):226-36
pubmed: 18221350
Arch Dis Child. 2013 May;98(5):323-7
pubmed: 23476001
Addiction. 2011 Feb;106(2):428-41
pubmed: 20925684
PLoS Med. 2020 Apr 17;17(4):e1003056
pubmed: 32302308
Glob Ment Health (Camb). 2016 Aug 12;3:e24
pubmed: 28596892
Lancet. 2012 Dec 15;380(9859):2197-223
pubmed: 23245608
AIDS Behav. 2022 Feb;26(2):523-536
pubmed: 34328570
Drug Alcohol Depend. 2016 Sep 01;166:85-92
pubmed: 27402551
Lancet. 2011 Nov 5;378(9803):1654-63
pubmed: 22008420
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
JAMA Pediatr. 2015 Aug;169(8):761-9
pubmed: 26111066
Int J Ment Health Syst. 2011 Nov 18;5(1):30
pubmed: 22099582
Am J Pharm Educ. 2007 Dec 15;71(6):109
pubmed: 19503693
JAMA. 2003 Jun 18;289(23):3117-24
pubmed: 12813117
JMIR Ment Health. 2016 Aug 03;3(3):e36
pubmed: 27489204
J Telemed Telecare. 2001;7(2):73-81
pubmed: 11331044
World Psychiatry. 2008;7(2):79-86
pubmed: 18560485
PLoS One. 2018 Dec 10;13(12):e0208483
pubmed: 30532155
Indian J Psychol Med. 2017 May-Jun;39(3):223-242
pubmed: 28615754
Lancet. 2010 Dec 18;376(9758):2086-95
pubmed: 21159375
AIDS Care. 2005 Oct;17(7):785-94
pubmed: 16120495
PLoS Med. 2014 Nov 11;11(11):e1001757
pubmed: 25386945
AIDS Care. 2018 Feb;30(2):160-167
pubmed: 29019254
Lancet. 2008 Sep 13;372(9642):902-9
pubmed: 18790313
BMC Psychiatry. 2015 Oct 14;15:249
pubmed: 26467303
Glob Ment Health (Camb). 2018 Apr 25;5:e16
pubmed: 29868236
J Contin Educ Health Prof. 2012 Summer;32(3):215-226
pubmed: 23173243
J Child Psychol Psychiatry. 2012 Apr;53(4):363-70
pubmed: 21883206
Am J Prev Med. 1996 Sep-Oct;12(5 Suppl):109-19
pubmed: 8909631
Addiction. 2002 Sep;97(9):1183-94
pubmed: 12199834
Psychiatr Serv. 2007 Nov;58(11):1493-6
pubmed: 17978264
Qual Life Res. 2010 Aug;19(6):875-86
pubmed: 20405245
Am J Reprod Immunol. 2013 Feb;69 Suppl 1:27-40
pubmed: 23176109
Int Rev Psychiatry. 2021 Feb-Mar;33(1-2):170-178
pubmed: 32462955
JAMA. 2007 Aug 1;298(5):519-27
pubmed: 17666672
Glob Ment Health (Camb). 2021 Aug 27;8:e32
pubmed: 34513001
AIDS Care. 2006 Apr;18(3):269-76
pubmed: 16546789
Behav Sci Law. 2008;26(3):315-22
pubmed: 18548517
AIDS Care. 2007 Mar;19(3):318-25
pubmed: 17453564

Auteurs

Caleb J Figge (CJ)

Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 615 N. Wolfe Street, Baltimore, MD, 21205, USA. cfigge1@jh.edu.

Jeremy C Kane (JC)

Department of Epidemiology, Columbia University Mailman School of Public Health, 722 W 168th St., New York City, NY, 10032, USA.

Stephanie Skavenski (S)

Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 615 N. Wolfe Street, Baltimore, MD, 21205, USA.

Emily Haroz (E)

Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 615 N. Wolfe Street, Baltimore, MD, 21205, USA.

Mwamba Mwenge (M)

The Centre for Infectious Disease Research (CIDRZ) Zambia, Plot 34620, Lusaka, Zambia.

Saphira Mulemba (S)

The Centre for Infectious Disease Research (CIDRZ) Zambia, Plot 34620, Lusaka, Zambia.

Luke R Aldridge (LR)

Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 615 N. Wolfe Street, Baltimore, MD, 21205, USA.

Michael J Vinikoor (MJ)

The Centre for Infectious Disease Research (CIDRZ) Zambia, Plot 34620, Lusaka, Zambia.
Department of Medicine, University of Alabama at Birmingham, 845 19th Street South, Birmingham, AL, 35294, USA.
Department of Medicine, University of Zambia, PO Box 50110, Lusaka, Zambia.

Anjali Sharma (A)

The Centre for Infectious Disease Research (CIDRZ) Zambia, Plot 34620, Lusaka, Zambia.

Sachi Inoue (S)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, 655 Huntington Ave, Boston, MA, 02115, USA.

Ravi Paul (R)

Department of Psychiatry, University of Zambia, PO Box 50110, Lusaka, Zambia.

Francis Simenda (F)

Ministry of Health Zambia, Haille Selassie Avenue, Ndeke House, P.O. Box 30205, Lusaka, Zambia.

Kristina Metz (K)

Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 615 N. Wolfe Street, Baltimore, MD, 21205, USA.

Carolyn Bolton (C)

The Centre for Infectious Disease Research (CIDRZ) Zambia, Plot 34620, Lusaka, Zambia.

Christopher Kemp (C)

Department of Global Health, Hans Rosling Center, University of Washington School of Public Health, 3980 15th Ave. NE, Seattle, WA, 98105, USA.

Samuel Bosomprah (S)

The Centre for Infectious Disease Research (CIDRZ) Zambia, Plot 34620, Lusaka, Zambia.

Izukanji Sikazwe (I)

The Centre for Infectious Disease Research (CIDRZ) Zambia, Plot 34620, Lusaka, Zambia.

Laura K Murray (LK)

Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 615 N. Wolfe Street, Baltimore, MD, 21205, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH